211 results on '"Picco, Agnese"'
Search Results
2. Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study
3. Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors
4. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease
5. Neuroimaging Findings in Mild Cognitive Impairment
6. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study
7. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
8. Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework
9. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
10. Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD
11. Neuroimaging Findings in Mild Cognitive Impairment
12. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
13. Early identification of MCI converting to AD: a FDG PET study
14. 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage
15. Prediction of cognitive worsening in de novo Parkinsonʼs disease: Clinical use of biomarkers
16. Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD
17. Parkinson’s Disease Sleep Scale 2: application in an Italian population
18. Brain 18F-DOPA PET and cognition in de novo Parkinson’s disease
19. Correlation between Doppler Velocities and Duplex Ultrasound Carotid Cross-sectional Percent Stenosis
20. Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints
21. Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques
22. Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study
23. Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly
24. Resting metabolic connectivity in Alzheimer’s disease
25. Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects
26. Una sfida per la scienza: Genesi ed evoluzione del pensiero di Cesare Lombroso sullo spiritismo.
27. Biomarkers validation in Alzheimer’s Disease and related pathologies
28. White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers
29. Amygdalar nuclei and hippocampal subfields on MRI: Test‐retest reliability of automated segmentation in old and young healthy volunteers
30. What predicts cognitive decline in de novo Parkinson's disease?
31. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease
32. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study
33. IC‐P‐006: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY)
34. P1‐393: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY)
35. IC‐P‐126: VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION
36. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
37. IC‐P‐006: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY).
38. Free water elimination improves test–retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects
39. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
40. [IC-P-167]: ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY
41. ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY
42. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
43. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes
44. Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study
45. Lupus nephritis and Cyclic Vomiting Syndrome: a case report
46. Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC)
47. Studio dell’attività serotoninergica troncoencefalica nel disturbo comportamentale del sonno REM
48. PSYCHOMETRIC PROPERTIES OF THE ITALIAN VERSION OF RESILIENCE SCALE IN ADULTS AND ELDERLY HEALTHY SUBJECTS
49. Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data
50. P3-209: Impact of Biomarkers On Diagnostic Confidence in Clinical Assessment of Patients with Suspected Alzheimer's Disease and High Diagnostic Uncertainty: An EADC Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.